Guilherme Perini: Would love to hear colleagues from Low- or Middle-Income Countries.

Guilherme Perini, Hematologist at Israelita Albert Einstein Hospital, shared a post by Bishal Gyawali on X/Twitter:

“Do any of the authors actually practice in Low- or Middle-Income Countries? No. I would gladly have as many trials as possible if I could get my patients new and better drugs. But maybe that’s just me. Would love to hear from my colleagues from Low- or Middle-Income Countries.”

Quoting Bishal Gyawali, Medical Oncologist at Queen’s University’s post:

Our new editorial is out today in BMJ Oncology on the globalization of cancer drug trials. Thanks, Kristina Jenei for leading this, and Fabio Moraes for the collaboration.”